Community-Acquired Pneumonia

Chapter 65


Community-Acquired Pneumonia



Pneumonia is defined as inflammation and consolidation of lung tissue resulting from an infectious agent. The eighth leading cause of death and responsible for more than 60,000 deaths annually in the United States, pneumonia is the most common infectious disease resulting in mortality. Although newer antimicrobial agents have been developed to treat community-acquired pneumonia (CAP), the incidence of this disease resulting from resistant pathogens continues to rise. Finally, increased populations at high risk, particularly those with acquired immunodeficiency disease or those receiving immunosuppressive therapy, contribute to the increasing importance of opportunistic pathogens as causes of CAP.


As a general rule, CAPs are present upon hospital admission or occur within the first 48 hours after admission—the latter were incubating at time of admission. In contrast, according to the American Thoracic Society’s (ATS) guidelines, health care–associated pneumonias (HCAPs) are defined as those that occur 48 hours or later after admission to a health care facility and were not incubating at the time of admission. However, pneumonias that are present upon hospital admission or shortly thereafter but occur in nonambulatory residents of a nursing home or other long-term care facility should be regarded as HCAPs and managed as such (see Chapter 14).



Clinical Diagnosis and Causes


Although the majority of patients with CAP present with the classic signs and symptoms of fever, cough, and sputum production, these signs and symptoms are neither sensitive nor specific. For example, elderly patients with CAP often show none of these traditional indicators of infection. Instead, the most reliable sign of pneumonia in this group is an increased respiratory rate.



Atypical versus Typical Pneumonia


Historically, some clinicians distinguished typical and atypical CAP based on clinical presentation. CAP caused by “atypical” organisms (Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella species, and viruses) was thought to be characterized by a prior viral-like syndrome (myalgias, arthralgias, and sore throat), subacute time course, nonproductive cough, absence of pleurisy and rigors, lower fever, and absence of consolidation on auscultation compared with CAP caused by “typical” organisms (Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and gram-negative bacteria). When studied systematically, however, these characteristics were no more common in atypical than in typical pneumonias. In addition, comparing laboratory data and chest radiographs failed to discriminate between patients with typical and atypical pneumonias. Clinical demographics may give clues to the cause, but definitive diagnosis depends on laboratory and microbiologic testing to identify a specific pathogen.



Pathogens


Many different organisms cause CAP. Although the isolation rate has decreased, S. pneumoniae (pneumococcus) remains the most frequently identified cause of CAP. Yet despite new diagnostic techniques, the cause of CAP remains unknown in up to 45% of cases. The most common pathogens identified (in descending order of frequency) are S. pneumoniae, H. influenzae, M. pneumoniae, C. pneumoniae, respiratory viruses, and Legionella species. The most common organisms in patients admitted to the intensive care unit (ICU) vary from all patients with CAP. For example, a review of nine studies that included 890 patients with CAP who were admitted to the ICU between 1999 and 2001 reported that the most common pathogens in the ICU population were (in descending order of frequency) S. pneumoniae, Legionella species, H. influenzae, Enterobacteriaceae species, S. aureus, and Pseudomonas species. About 20% of CAP in ICU patients may be due to atypical, most likely Legionella, species.


Because initial CAP treatment is often empirical, knowledge of the most likely pathogens is vital. The causative organism may be suspected based on the patient’s risk factors or comorbid illnesses (Table 65.1). S. pneumoniae, however, remains the most common cause in all groups including those with human immunodeficiency virus (HIV). Severe recurrent pneumonias with S. pneumoniae or H. influenzae suggest an underlying immunocompromised state—for example, HIV infection or multiple myeloma. Legionella infections by non-pneumophila species may also be more common in immunosuppressed patients and warrant assessment of the patient’s immune status. Viruses may cause up to 30% of CAP. Although the most prevalent respiratory virus is influenza, others such as adenovirus, respiratory syncytial virus (RSV), and parainfluenza are also common.



TABLE 65.1


Commonly Encountered Pathogens for Community-Acquired Pneumonia According to Specific Conditions or Risk Factors











































































Condition Commonly Encountered Pathogen(s)
Alcoholism Streptococcus pneumoniae, oral anaerobes, Klebsiella pneumoniae, Acinetobacter species, Mycobacterium tuberculosis
Aspiration Gram-negative enteric pathogens, oral anaerobes
COPD or smoking Haemophilus influenzae, Pseudomonas aeruginosa, Legionella species, S. pneumoniae, Moraxella catarrhalis, Chlamydophila pneumonia
Cough for 12 weeks with whoop or posttussive vomiting Bordetella pertussis
Endobronchial obstruction Anaerobes, S. pneumoniae, H. influenzae, Staphylococcus aureus
Exposure to bat or bird droppings Histoplasma capsulatum
Exposure to birds Chlamydophila psittaci (if poultry: avian influenza)
Exposure to farm animals or parturient cats Coxiella burnetii (Q fever)
Exposure to rabbits Francisella tularensis
HIV infection (early) S. pneumoniae, H. influenzae, Mycobacterium tuberculosis
HIV infection (late) The pathogens listed for early infection plus Pneumocystis jiroveci, Cryptococcus, Histoplasma, Aspergillus, atypical mycobacteria (especially Mycobacterium kansasii), P. aeruginosa, H. influenza
Hotel or cruise ship stay in previous 2 weeks Legionella species
In context of bioterrorism Bacillus anthracis (anthrax), Yersinia pestis (plague), Francisella tularensis (tularemia)
Influenza active in community Influenza, S. pneumoniae, Staphylococcus aureus, H. influenzae
Injection drug use S. aureus, anaerobes, M. tuberculosis, S. pneumoniae
Lung abscess CA-MRSA, oral anaerobes, endemic fungal pneumonia, M. tuberculosis, atypical mycobacteria
Neutropenia S. pneumoniae, gram-negative bacilli (especially, Pseudomonas aeruginosa)
Nursing home residents S. pneumoniae, gram-negative bacilli (especially, Klebsiella pneumoniae), influenza A or B, S. aureus, oral anaerobes, M. tuberculosis
Solid organ transplant recipients > 3 months after transplant S. pneumonia, H. influenza, Legionella species, Pneumocystis jiroveci, Cytomegalovirus
Structural lung disease (e.g., bronchiectasis) Pseudomonas aeruginosa, Burkholderia cepacia, S. aureus
Travel to or residence in Southeast and East Asia Burkholderia pseudomallei, avian influenza, SARS
Travel to or residence in southwestern United States Coccidioides species, Hantavirus
Young adults (age < 30) Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae

CA-MRSA, community-acquired methicillin-resistant Staphylococcus aureus; COPD, chronic obstructive pulmonary disease; SARS, severe acute respiratory syndrome.


Pneumonia in nonambulatory residents of nursing homes and other long-term care facilities should be considered a health care–associated pneumonia (HCAP) as described in Chapter 14.


Adapted from Mandell LA, Wunderink RG, Anzueto A, et al: Infectious Diseases Society of America/American Thoracic Society consensus guideline on the management of community-acquired pneumonia in adults. Clin Infect Dis 44:S27-S72, 2007.



Diagnostic Evaluation




Gram Stain and Culture of Sputum


Although its value has been widely debated, a Gram stain and culture of expectorated sputum may establish the cause of CAP and guide initial therapy. Although only 60% to 70% of patients with CAP can produce sputum on hospital admission, these sputum tests are non-invasive and relatively inexpensive. In patients eventually diagnosed with pneumonia resulting from S. pneumoniae, 62% to 89% demonstrate lancet-shaped gram-positive diplococci on initial Gram stain. Alternatively, finding many polymorphonuclear neutrophils and no organisms on Gram stain suggests infection with M. pneumoniae, C. pneumoniae, or Legionella species.


Sputum cultures must be interpreted in light of the findings of the corresponding sputum Gram stain. Isolation of a predominant organism by culture is clinically compelling when compatible with the Gram stain findings. Isolation of a predominant organism that is not part of the normal respiratory flora may be useful in modifying antibiotics. Similarly, failure to find organisms such as S. aureus or gram-negative bacilli on Gram stain or in culture suggests they are truly absent. Because of difficulty in isolation, cultures for M. pneumoniae, C. pneumoniae, Legionella species, and respiratory viruses are not routinely performed.


The clinical value of a sputum Gram stain and culture depends largely on the quality of the sputum specimen. Having > 25 polymorphonuclear neutrophils and < 10 squamous epithelial cells per low-power field can determine whether the sputum is an adequate sample from the lower respiratory tract. Prior antibiotic therapy decreases the usefulness of sputum cultures, because the chance of isolating an organism from sputum decreases by up to 50% after just one to two doses of antibiotic. Bronchoscopy and bronchoalveolar lavage often increase the yield of Gram stain and culture but are usually reserved for patients who do not respond to initial empirical antibiotics, are critically ill, or may harbor resistant or uncommon organisms.

< div class='tao-gold-member'>

Jul 7, 2016 | Posted by in CRITICAL CARE | Comments Off on Community-Acquired Pneumonia

Full access? Get Clinical Tree

Get Clinical Tree app for offline access